## Abstract Potential risk factors for the development of hepatocellular carcinoma were analysed in 40 Caucasian patients with this malignancy. A higher proportion (14 of 40; 35%) had evidence of hepatitis C virus (HCV) infection than had evidence of either hepatitis B virus (HBV) carriage (17.5%)
Hepatitis C viraemia in adults with type 2 autoimmune hepatitis
β Scribed by Dr. J. A. Garson; M. Lenzi; C. Ring; F. Cassani; G. Ballardini; M. Briggs; R. S. Tedder; F. B. Bianchi
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 475 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Sera from 14 patients with type 2 autoimmune hepatitis (antiβLKM, positive) were investigated for evidence of hepatitis C virus (HCV) infection. Antibodies to HCV were detected in 13 patients by both commercial and βinβhouseβ ELlSAs and also by a second generation recombinant immunoblot assay. Nine of the 13 (69%) antiβHCV positive patients were shown to be viraemic by a polymerase chain reactionβbased assay for serum HCV RNA. Neither antiβHCV nor serum HCV RNA were detected in any of 6 controls with primary biliary cirrhosis or in 39 healthy blood donors. These findings strongly suggest a role for HCV in the pathogenesis of type 2 autoimmune hepatitis.
π SIMILAR VOLUMES
To evaluate the histological findings in patients with chronic hepatitis C and autoimmune features, liver tissue specimens from 60 patients were graded under code for individual features and composite patterns that denoted autoimmune, viral, combined autoimmune and viral, and nondiscriminative chang
## Abstract A quantitative polymerase chain reaction (PCR) assay for hepatitis C viral RNA (HCVβRNA) was used to monitor viraemia levels in six patients at multiple time points before, during, and after interferon therapy for chronic nonβA, nonβB hepatitis (NANBH). Prior to therapy, serum HCVβRNA w
Perinuclear anti-neutrophil cytoplasmic antibodies (pANCA) have been recently defined as the most sensitive autoantibody of type 1 autoimmune hepatitis (AIH-1). Their prevalence in type 2 autoimmune hepatitis (AIH-2) has not yet been evaluated. The aim of the present study was to verify the associat
Autoimmune hepatitis (AIH) is characterized by an immune-mediated injury of the hepatic parenchyma of unknown pathogenesis. Type 2 AIH is identified by the presence of antiliver-kidney microsomes type 1 (anti-LKM1) and anti-liver cytosol type 1 (anti-LC1) autoantibodies. The current study shows that